Who owns Metagenomi Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MGX from SEC Form 13F filings across 44 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 44 institutions disclosed 6.0M shares of Metagenomi Therapeutics, Inc. worth $6.4M — about 15.9% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
44
13F holders
$6.4M
value, 2026 filers
15.9%
of shares outstanding (6.0M sh)
6
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MGX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $1.1M | 0.0% | 2.9% | 0.0% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 624,300 | $661,758 | 0.0% | 1.7% | -15.9% |
| 3 | Catalio Capital Management, LP | 528,993 | $560,733 | 0.1% | 1.4% | 0.0% |
| 4 | TWO SIGMA INVESTMENTS, LP | 504,515 | $534,786 | 0.0% | 1.3% | -1.8% |
| 5 | Peapod Lane Capital LLC | 490,992 | $520,452 | 0.4% | 1.3% | -6.5% |
| 6 | WELLS FARGO & COMPANY/MN | 424,687 | $450,168 | 0.0% | 1.1% | +11.9% |
| 7 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 375,300 | $397,818 | 0.0% | 1% | -6.2% |
| 8 | Almitas Capital LLCNEW | 282,308 | $299,246 | 0.1% | 0.7% | new |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 275,088 | $291,738 | 0.0% | 0.7% | -4.7% |
| 10 | BlackRock, Inc. | 253,235 | $268,429 | 0.0% | 0.7% | -1.7% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 171,251 | $181,526 | 0.0% | 0.5% | 0.0% |
| 12 | Man Group plc | 141,896 | $150,410 | 0.0% | 0.4% | +30.0% |
| 13 | STATE STREET CORP | 119,850 | $127,041 | 0.0% | 0.3% | 0.0% |
| 14 | Resolute Advisors LLC | 89,944 | $95,341 | 0.0% | 0.2% | 0.0% |
| 15 | MILLENNIUM MANAGEMENT LLC | 75,402 | $79,926 | 0.0% | 0.2% | -33.9% |
| 16 | NORTHERN TRUST CORP | 68,938 | $73,074 | 0.0% | 0.2% | 0.0% |
| 17 | RBF Capital, LLC | 64,021 | $67,862 | 0.0% | 0.2% | 0.0% |
| 18 | BBR PARTNERS, LLC | 53,403 | $56,607 | 0.0% | 0.1% | 0.0% |
| 19 | HRT FINANCIAL LPNEW | 52,288 | $55,000 | 0.0% | 0.1% | new |
| 20 | CITADEL ADVISORS LLC | 49,266 | $52,222 | 0.0% | 0.1% | +176.0% |
| 21 | EFG International AGNEW | 37,510 | $39,732 | 0.0% | 0.1% | new |
| 22 | Fortitude Advisory Group L.L.C. | 37,290 | $39,527 | 0.0% | 0.1% | +0.3% |
| 23 | Empowered Funds, LLCNEW | 37,200 | $39,432 | 0.0% | 0.1% | new |
| 24 | XTX Topco Ltd | 32,499 | $34,449 | 0.0% | 0.1% | -41.7% |
| 25 | TWO SIGMA SECURITIES, LLC | 28,109 | $29,796 | 0.0% | 0.1% | +85.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.